Page last updated: 2024-09-05

wy 41770 and dinoprostone

wy 41770 has been researched along with dinoprostone in 1 studies

Compound Research Comparison

Studies
(wy 41770)
Trials
(wy 41770)
Recent Studies (post-2010)
(wy 41770)
Studies
(dinoprostone)
Trials
(dinoprostone)
Recent Studies (post-2010) (dinoprostone)
50029,1051,3466,357

Protein Interaction Comparison

ProteinTaxonomywy 41770 (IC50)dinoprostone (IC50)
Prostaglandin E2 receptor EP1 subtypeHomo sapiens (human)0.0155
Prostaglandin E2 receptor EP4 subtypeHomo sapiens (human)0.0031
Prostaglandin E2 receptor EP4 subtypeRattus norvegicus (Norway rat)0.0021
Prostaglandin E2 receptor EP3 subtypeHomo sapiens (human)0.002
Prostaglandin E2 receptor EP2 subtypeHomo sapiens (human)0.0087
Prostacyclin receptorHomo sapiens (human)0.26
Prostaglandin E2 receptor EP2 subtypeRattus norvegicus (Norway rat)0.0052

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carlson, RP; Chang, J; Datko, LJ; Lewis, AJ; Nielsen, ST1

Other Studies

1 other study(ies) available for wy 41770 and dinoprostone

ArticleYear
The antiinflammatory profile of (5H-dibenzo[a,d]-cyclohepten-5-ylidene)acetic acid (WY-41,770), an agent possessing weak prostaglandin synthetase inhibitory activity that is devoid of gastric side effects.
    Agents and actions, 1984, Volume: 14, Issue:5-6

    Topics: Acetates; Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Carrageenan; Cyclooxygenase Inhibitors; Dibenzocycloheptenes; Digestive System; Dinoprostone; Edema; Fever; Hyperesthesia; In Vitro Techniques; Irritants; Lipoxygenase Inhibitors; Macrophages; Male; Platelet Aggregation; Pleurisy; Prostaglandins; Prostaglandins E; Rats; Rats, Inbred Strains; Seminal Vesicles; Synovitis; Yeast, Dried

1984